- Home
- RMAX vs STIM Comparison
RMAX vs STIM Comparison
Compare RMAX & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMAX
- STIM
- Stock Information
- Founded
- RMAX 1973
- STIM 2003
- Country
- RMAX United States
- STIM United States
- Employees
- RMAX N/A
- STIM N/A
- Industry
- RMAX Real Estate
- STIM Medical/Dental Instruments
- Sector
- RMAX Finance
- STIM Health Care
- Exchange
- RMAX Nasdaq
- STIM Nasdaq
- Market Cap
- RMAX 187.5M
- STIM 224.8M
- IPO Year
- RMAX 2013
- STIM 2018
- Fundamental
- Price
- RMAX $7.93
- STIM $2.65
- Analyst Decision
- RMAX Hold
- STIM Strong Buy
- Analyst Count
- RMAX 1
- STIM 2
- Target Price
- RMAX $9.00
- STIM $7.00
- AVG Volume (30 Days)
- RMAX 150.4K
- STIM 1.0M
- Earning Date
- RMAX 10-30-2025
- STIM 11-04-2025
- Dividend Yield
- RMAX N/A
- STIM N/A
- EPS Growth
- RMAX N/A
- STIM N/A
- EPS
- RMAX 0.62
- STIM N/A
- Revenue
- RMAX $292,931,000.00
- STIM $111,106,000.00
- Revenue This Year
- RMAX N/A
- STIM $105.70
- Revenue Next Year
- RMAX N/A
- STIM $11.77
- P/E Ratio
- RMAX $12.82
- STIM N/A
- Revenue Growth
- RMAX N/A
- STIM 54.17
- 52 Week Low
- RMAX $6.90
- STIM $0.52
- 52 Week High
- RMAX $14.31
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- RMAX 33.21
- STIM 39.85
- Support Level
- RMAX $8.18
- STIM $2.61
- Resistance Level
- RMAX $8.68
- STIM $3.23
- Average True Range (ATR)
- RMAX 0.26
- STIM 0.22
- MACD
- RMAX -0.02
- STIM -0.01
- Stochastic Oscillator
- RMAX 29.32
- STIM 7.20
About RMAX RE/MAX Holdings Inc.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.